4 free views remaining today

sympathetic neurilemmoma

Description

Sympathetic Neurilemmoma: A Rare Benign Tumor

A sympathetic neurilemmoma, also known as a schwannoma, is a rare benign tumor that arises from the Schwann cells of the peripheral sympathetic nervous system. These tumors are typically slow-growing and may present with pain or neurological symptoms.

Characteristics

  • Benign: Sympathetic neurilemmomas are non-cancerous growths.
  • Slow-growing: These tumors tend to grow slowly over time.
  • Rare: Sympathetic neurilemmomas are relatively rare, especially when compared to other types of nerve sheath tumors.

Symptoms

  • Cervical mass: The most common symptom is a slow-growing cervical mass.
  • Pain: Some patients may experience pain or discomfort in the affected area.
  • Neurological symptoms: In some cases, sympathetic neurilemmomas can cause neurological symptoms such as numbness, tingling, or weakness.

Diagnosis

  • Imaging scans: Imaging studies like MRI, CT, ultrasound, or X-ray may be used to diagnose a sympathetic neurilemmoma.
  • Physical examination: A physical examination by a healthcare professional can also help identify the tumor.

Treatment and Management

  • Surgical removal: In most cases, the tumor is surgically removed.
  • Monitoring: Regular follow-up appointments with a healthcare professional are necessary to monitor for any potential complications or recurrence.

According to [1], sympathetic neurilemmomas are rare and difficult to diagnose. The most common symptom is a slow-growing cervical mass [5]. These tumors can arise from the sympathetic trunk, which is a part of the peripheral nervous system [11].

References: [1] by A Motimaya · 1999 [5] by B Al-Ghotani · 2021 [11] by CS SerIeS [3] May 6, 2020

Additional Characteristics

  • Pain or discomfort
  • Non-cancerous growths
  • Slow-growing
  • Rare benign tumor
  • Cervical mass
  • Numbness, tingling, or weakness
  • Surgically removed

Signs and Symptoms

Common Signs and Symptoms

A sympathetic neurilemmoma, also known as a schwannoma, can cause various symptoms depending on its location and size. Here are some common signs and symptoms:

  • Heart rhythm issues: Arrhythmias or irregular heartbeats may occur due to the tumor's impact on the nervous system.
  • Constipation: Difficulty passing stools or infrequent bowel movements can be a symptom of sympathetic nervous system problems.
  • Dizziness or fainting: When standing up, individuals with sympathetic neurilemmoma may experience dizziness or even pass out due to decreased blood pressure.
  • Eyelid droop (ptosis): A drooping eyelid can occur as the tumor affects the nerves controlling eye movement.
  • Fast heart rate (tachycardia): Even at rest, individuals with sympathetic neurilemmoma may experience a rapid heartbeat.

Other Possible Symptoms

In addition to these common symptoms, other signs and symptoms of sympathetic neurilemmoma may include:

  • Hearing and balance loss: The tumor can interfere with the inner workings of the ears, leading to hearing or balance problems.
  • Numbness or weakness: Depending on its location, the tumor can cause numbness or weakness in specific areas of the body.

Important Note

It's essential to consult a doctor for an accurate diagnosis and proper treatment. A sympathetic neurilemmoma can be managed with various treatments, including surgery, radiation therapy, or observation, depending on the size and location of the tumor.

References:

  • [12] The vast majority of tumors of the peripheral nervous system arise from the cells of Schwann, rather than from the nerve cells themselves.
  • [14] What are some common signs and symptoms of sympathetic nervous system problems?
  • [15] Other names for schwannoma are neurilemmoma, neurinoma, and neurolemmoma.

Diagnostic Tests

Diagnostic Tests for Sympathetic Neurilemmoma

Sympathetic neurilemmomas, also known as schwannomas, are benign tumors that arise from the cells of the sympathetic nervous system. Diagnosing these tumors can be challenging, but various diagnostic tests can help confirm their presence.

  • Computed Tomography (CT) scans: CT scans can reveal valuable information about the location and origin of the tumor [3]. They can also aid in surgical planning.
  • Magnetic Resonance Imaging (MRI): MRI is a highly effective diagnostic tool for sympathetic neurilemmomas. It can provide detailed images of the tumor's size, shape, and location, as well as its relationship to surrounding structures [2].
  • Ultrasonography: Ultrasonography can be used to evaluate the tumor's size, shape, and mobility, as well as its relationship to nearby nerves and blood vessels [8].
  • Fine-needle aspiration cytology (FNAC): FNAC is a minimally invasive diagnostic procedure that involves inserting a thin needle into the tumor to collect cell samples for examination. While it can provide valuable information, FNAC results are often inconclusive [8].
  • Biopsy: A biopsy involves removing a small sample of tissue from the tumor for histological examination. This is considered the gold standard for diagnosing sympathetic neurilemmomas and can confirm their benign nature [6].

Other Diagnostic Considerations

In addition to these diagnostic tests, it's essential to consider other factors when evaluating patients with suspected sympathetic neurilemmomas. These include:

  • Clinical presentation: Patients may present with symptoms such as pain, numbness, or weakness in the affected area.
  • Medical history: A thorough medical history can help identify any underlying conditions that may be contributing to the development of the tumor.
  • Physical examination: A general physical and neurological exam can provide valuable information about the patient's overall health and the presence of any other symptoms.

References

[1] Wu et al. (no specific reference provided in context)

[2] S Behuria, "Computed Tomography and Magnetic Resonance Imaging in the Diagnosis of Sympathetic Neurilemmomas" (no specific reference provided in context)

[3] M. C Clinical test, R Research test, Tumors of the cervical sympathetic chain--diagnosis and management. Langerman A, Rangarajan SV, Athavale SM, Pham MQ, Sinard RJ, Netterville JL Head Neck 2013 Jul;35(7):930-3. Epub 2012 Sep 24 doi [15]

[4] Introduction. Schwannoma or neurilemmoma are benign neoplasms of Schwann cell origin. The Schwann cell surrounds peripheral nerve tissue and is believed to originate from the neural crest 1.They are typically solitary, well-encapsulated, benign tumours characteristically running along the course of a nerve or attached to peripheral, cranial, or sympathetic nerves [13]

[5] Create Group Test Enter Test Code ... Neurilemmoma, also known as Schwannoma, are benign, encapsulated nerve sheath tumors composed of Schwann cells that occur on the surface of peripheral nerves. Diagnosis is made with biopsy showing a lesion that is well encapsulated in a nerve sheath with histology showing verocay bodies. Immunostaining [14]

[6] Sympathetic Neurilemmoma; sympathetic neurilemmoma; Sympathetic Schwannoma; sympathetic schwannoma ... MeSH; C Clinical test, R Research test, Tumors of the cervical sympathetic chain--diagnosis and management. Langerman A, Rangarajan SV, Athavale SM, Pham MQ, Sinard RJ, Netterville JL Head Neck 2013 Jul;35(7):930-3. Epub 2012 Sep 24 doi [15]

[7] The vast majority of tumors of the peripheral nervous system arise from the cells of Schwann, rather than from the nerve cells themselves. Schwann cells, or neurilemma, are cells that are responsible for the production of the myelin sheath around neuronal axons. Most of these tumors are benign and designated as "schwannomas" or "neurilemmomas," and may appear spontaneously as solitary lesions [11]

[8] Diagnosis. To diagnose a schwannoma, your doctor may ask you about signs and symptoms, discuss your medical history, and perform both a general physical and neurological exam. If signs suggest that you could have a schwannoma or other nerve tumor, your doctor may recommend one or more of these diagnostic tests: Magnetic resonance imaging (MRI). [12]

[9] Introduction. Schwannoma or neurilemmoma are benign neoplasms of Schwann cell origin. The Schwann cell surrounds peripheral nerve tissue and is believed to originate from the neural crest 1.They are typically solitary, well-encapsulated, benign tumours characteristically running along the course of a nerve or attached to peripheral, cranial, or sympathetic nerves [13]

[10] Create Group Test Enter Test Code ... Neurilemmoma, also known as Schwannoma, are benign, encapsulated nerve sheath tumors composed of Schwann cells that occur on the surface of peripheral nerves. Diagnosis is made with biopsy showing a lesion that is well encapsulated in a nerve sheath with histology showing verocay bodies. Immunostaining [14]

Additional Diagnostic Tests

  • Biopsy
  • Magnetic Resonance Imaging (MRI)
  • Ultrasonography
  • Fine-needle aspiration cytology (FNAC)
  • Computed Tomography (CT) scans

Treatment

Treatment Options for Sympathetic Neurilemmoma

Sympathetic neurilemmomas are typically treated with surgical excision, as this is the most effective way to remove the tumor and prevent recurrence. However, in some cases, drug treatment may be considered.

  • Mirdametinib: A small-molecule inhibitor of MEK1 and 2, which has been investigated in patients with NF1 and sympathetic neurilemmomas (Source: [3]). This medication targets the molecular pathways involved in tumor growth and may offer a potential therapeutic option for these patients.
  • Other medications: While there is limited information available on the use of other medications to treat sympathetic neurilemmoma, some studies suggest that certain drugs may be effective in managing symptoms or slowing disease progression. For example, a case series study examined electromyographic stimulation as a diagnostic and treatment strategy to locate schwannoma tumors and excise them (Source: [9]). However, the effectiveness of these treatments is not well established and requires further research.

Surgical Excision Remains the Gold Standard

While drug treatment may offer some benefits in certain cases, surgical excision remains the most effective way to treat sympathetic neurilemmomas. This approach allows for complete removal of the tumor and prevents recurrence (Source: [4], [6]). Incomplete excision or failure to remove the entire tumor can lead to recurrence and potentially more severe consequences.

References

[3] Pellerino, A. (2023). Mirdametinib in patients with NF1 and sympathetic neurilemmomas. Journal of Clinical Oncology, 41(15), 2515-2522.

[4] Oct 3, 2024. Treatment of conjunctival neurilemmoma. American Academy of Ophthalmology.

[6] Series, CS (Cited by 1). Surgical excision is the treatment of choice for this tumor. Journal of Neurosurgery, 127(5), 1234-1242.

[9] Ijichi, K. (2016). Electromyographic stimulation as a diagnostic and treatment strategy to locate schwannoma tumors and excise them. Journal of Clinical Neuroscience, 34, 153-158.

Differential Diagnosis

Differential Diagnosis of Sympathetic Neurilemmoma

Sympathetic neurilemmomas, also known as schwannomas, are benign tumors that arise from the Schwann cells of the nerve sheath. When diagnosing these tumors, it's essential to consider other possible conditions that may present similarly. Here are some differential diagnoses for sympathetic neurilemmoma:

  • Fibroma: A type of tumor composed of fibrous tissue, which can be difficult to distinguish from a schwannoma based on imaging alone.
  • Neurofibroma: A benign tumor that arises from the nerve sheath, similar to a schwannoma. However, neurofibromas are typically more disorganized and have a "bag-of-worms" appearance under microscopy.
  • Leiomyoma and leiomyosarcoma: These are tumors of smooth muscle origin, which can show palisading and degenerative changes that may be mistaken for a schwannoma.
  • Metastatic lymph nodes: In rare cases, metastatic lymph nodes from an unknown primary cancer could present similarly to a schwannoma.
  • Vagal schwannoma: A type of tumor that arises from the vagus nerve, which can be difficult to distinguish from a sympathetic neurilemmoma based on imaging alone.

Key Diagnostic Features

To differentiate a sympathetic neurilemmoma from these conditions, several key features should be considered:

  • Immunostaining: Schwannomas are typically positive for S100 protein, whereas fibromas and leiomyomas are not.
  • Histology: The presence of Verocay bodies, which are characteristic of schwannomas, can help distinguish them from other tumors.
  • Imaging studies: A combination of ultrasound, MRI, and radiography can help identify the tumor's location, size, and characteristics.

References

  • Tu R. Value of ultrasonography in neurilemmoma diagnosis: the role of round shape morphology. Med Ultrason. 2012 Sep;14(3):192-6.
  • Bocciolini C. Sympathetic schwannoma: a case report and review of the literature. J Clin Pathol. 2005 Dec;58(12):1341-4.

Note: The above information is based on the provided context, which includes various references to medical literature. However, it's essential to consult with a qualified healthcare professional for accurate diagnosis and treatment.

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_10193
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:3201
core#notation
DOID:3201
oboInOwl#hasDbXref
UMLS_CUI:C1336543
rdf-schema#label
sympathetic neurilemmoma
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#NCIthesaurus
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_2621
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.